共享集團(03344.HK):聆訊暫時重新定於2021年3月12日進行
格隆匯 12 月 30日丨共享集團(03344.HK)公佈,此前披露公司就准許召開計劃會議的申請可定於2020年12月22日進行聆訊,以及為批准建議安排計劃的聆訊將定於2021年2月23日進行。就准許召開計劃會議之申請已於2020年12月22日上午十一時正進行聆訊。於聆訊中,高等法院已就編制有關安排計劃的文件作出指示,且公司將作出進一步提交,以供高等法院批准。此外,為批准建議安排計劃的聆訊暫時重新定於2021年3月12日進行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.